MUM1 Antibody from MYBIOSOURCE INC.
Search, find, compare suppliers for anti-MUM1 antibody, protein, ELISA kits.
| Edit | |
|---|---|
| Antigenic Specificity | MUM1 |
| Clone | monoclonal |
| Host Species | Mouse |
| Reactive Species | human |
| Isotype | IgG1 |
| Format | affinity purified |
| Size | 0.05 mL, 0.1 mL, 0.2 mL |
| Concentration | 1mg/ml |
| Applications | Western Blot (WB), Immunohistochemistry (IHC), ELISA (EIA) |
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
| Description | Specificity: MUM1 antibody detects endogenous levels of total MUM1. Description: Mutated melanoma-associated antigen 1 (MUM1) is a 78 kDa protein encoded by the MUM1 gene. MUM1 is expressed in a subset of B cells in the light zone of the germinal center, plasma cells, activated T cells and a wide spectrum of related hematolymphoid neoplasms. Antibodies to MUM1 are useful in the sub classification of lymphoid malignancies. |
| Immunogen | Immunogen: Purified recombinant fragment of human MUM1 expressed in E. Coli Subcellular Location: Nucleus. Recuited to DNA damage sites via its interaction with the BRCT domain of TP53BP1. |
| Other Names | [EXPAND1; FLJ14868; FLJ22283; HSPC211; Melanoma associated antigen (mutated) 1; Melanoma ubiquitous mutated protein; MGC131891; MGC163315; MUM 1; MUM-1; MUM1; MUM1_HUMAN; Mutated melanoma associated antigen 1; Mutated melanoma-associated antigen 1; Protein expandere; PWWP domain containing protein MUM1; PWWP domain-containing protein MUM1] |
| Gene, Accession # | [MUM1], Gene ID: 84939, NCBI: NP_116242.2, UniProt: Q2TAK8 |
| Catalog # | MBS9602688 |
| Price | $235, $295, $370 |
| Order / More Info | MUM1 Antibody from MYBIOSOURCE INC. |
| Product Specific References | n/a |
MYBIOSOURCE INC.
MYBIOSOURCE INC.
P.O. Box 153308
San Diego CA 92195-3308
P: 1.858.633.0165
P: 1.888.MBS.0165 (1.888.627.0165) (US & Canada)
F: 1.858.633.0166
sales@mybiosource.com
http://www.MyBioSource.com
Profile of MYBIOSOURCE INC.
Return to Antibodies